Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May 1;201(9):1022-1023.
doi: 10.1164/rccm.202002-0459ED.

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease

Peter M A Calverley  1
Affiliations
Editorial

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease

Peter M A Calverley. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946. [Published erratum appears in Eur Respir J 27:242.] - PubMed
    1. Wedzicha JA, Calverley PMA, Albert RK, Anzueto A, Criner GJ, Hurst JR, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;50:1602265. - PubMed
    1. Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. American Thoracic Society Assembly on Clinical Problems. Pharmacologic management of chronic obstructive pulmonary disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e56–e69. - PMC - PubMed
    1. Hopkinson NS, Molyneux A, Pink J, Harrisingh MC. Guideline Committee (GC) Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance. BMJ. 2019;366:l4486. - PubMed
    1. Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018;6:117–126. - PubMed